Ronit Capital LLP Nuvectis Pharma, Inc. Transaction History
Ronit Capital LLP
- $74.3 Million
- Q3 2022
A detailed history of Ronit Capital LLP transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Ronit Capital LLP holds 562,547 shares of NVCT stock, worth $3.84 Million. This represents 5.37% of its overall portfolio holdings.
Number of Shares
562,547
Previous 419,282
34.17%
Holding current value
$3.84 Million
Previous $4.7 Million
15.08%
% of portfolio
5.37%
Previous 6.66%
Shares
3 transactions
Others Institutions Holding NVCT
# of Institutions
49Shares Held
3.21MCall Options Held
44.5KPut Options Held
50.1K-
Vanguard Group Inc Valley Forge, PA667KShares$4.55 Million0.0% of portfolio
-
Iridian Asset Management LLC373KShares$2.55 Million1.01% of portfolio
-
Baldwin Brothers LLC350KShares$2.39 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA285KShares$1.95 Million0.0% of portfolio
-
State Street Corp Boston, MA114KShares$775,7440.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $100M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...